Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer℉s disease model

Jean Cosme Dodart, Kelly R. Bales, Kimberley S. Gannon, Stephen J. Greene, Ronald B. DeMattos, Chantal Mathis, Cynthia A. DeLong, Su Wu, Xin Wu, David M. Holtzman, Steven M. Paul

Research output: Contribution to journalArticlepeer-review

826 Scopus citations

Abstract

We have previously shown that chronic treatment with the monoclonal antibody m266, which is specific for amyloid β-peptide (Aβ), increases plasma concentrations of Aβ and reduces Aβ burden in the PDAPP transgenic mouse model of Alzheimer's disease (AD). We now report that administration of m266 to PDAPP mice can rapidly reverse memory deficits in both an object recognition task and a holeboard learning and memory task, but without altering brain Aβ burden. We also found that an Aβ/antibody complex was present in both the plasma and the cerebrospinal fluid of m266-treated mice. Our data indicate that passive immunization with this anti-Aβ monoclonal antibody can very rapidly reverse memory impairment in certain learning and memory tasks in the PDAPP mouse model of AD, owing perhaps to enhanced peripheral clearance and (or) sequestration of a soluble brain Aβ species.

Original languageEnglish
Pages (from-to)452-457
Number of pages6
JournalNature neuroscience
Volume5
Issue number5
DOIs
StatePublished - May 2002

Fingerprint

Dive into the research topics of 'Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer℉s disease model'. Together they form a unique fingerprint.

Cite this